AbbVie
ABBV
#29
Rank
$380.24 B
Marketcap
$214.98
Share price
-1.15%
Change (1 day)
6.09%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : $137.18 Billion USD

According to AbbVie's latest financial reports the company's total liabilities are $137.18 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31$137.18 B4.09%
2024-12-31$131.79 B6.02%
2023-12-31$124.31 B2.3%
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.54%
2014-12-31$25.77 B4.31%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B211.57%
2011-12-31$7.58 B39.72%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$121.38 B-11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.94 B-37.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$81.92 B-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$11.18 B-91.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$36.40 B-73.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$71.53 B-47.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$65.35 B-52.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$60.82 B-55.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$1.37 B-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA